The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Patel, Romil Surendra
    Director born in July 1979
    Individual (9 offsprings)
    Officer
    2025-04-04 ~ now
    OF - Director → CIF 0
  • 2
    104, Holland Park Avenue, London, England
    Active Corporate (3 parents, 1 offspring)
    Person with significant control
    2025-04-04 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 1
  • Patel, Ila
    Director born in November 1952
    Individual (6 offsprings)
    Officer
    2018-07-02 ~ 2025-04-04
    OF - Director → CIF 0
    Mrs Ila Patel
    Born in November 1952
    Individual (6 offsprings)
    Person with significant control
    2018-07-02 ~ 2025-04-04
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

ELLEPHARM INVESTMENTS LIMITED

Standard Industrial Classification
64209 - Activities Of Other Holding Companies N.e.c.
Brief company account
Current assets - Investments
1,212,443 GBP2023-07-31
1,212,443 GBP2022-07-31
Cash at bank and in hand
1 GBP2023-07-31
1 GBP2022-07-31
Current Assets
1,212,444 GBP2023-07-31
1,212,444 GBP2022-07-31
Creditors
-1,800 GBP2023-07-31
-1,440 GBP2022-07-31
Net Current Assets/Liabilities
1,210,644 GBP2023-07-31
1,211,004 GBP2022-07-31
Total Assets Less Current Liabilities
1,210,644 GBP2023-07-31
1,211,004 GBP2022-07-31
Net Assets/Liabilities
1,210,644 GBP2023-07-31
1,211,004 GBP2022-07-31
Equity
Called up share capital
101 GBP2023-07-31
101 GBP2022-07-31
Retained earnings (accumulated losses)
-1,800 GBP2023-07-31
-1,440 GBP2022-07-31
Average number of employees in administration and support functions
12022-08-01 ~ 2023-07-31
12021-08-01 ~ 2022-07-31
Average Number of Employees
12022-08-01 ~ 2023-07-31
12021-08-01 ~ 2022-07-31

Related profiles found in government register
  • ELLEPHARM INVESTMENTS LIMITED
    Info
    Registered number 11443145
    C/o Zane Partnership, 925 Finchley Road, London NW11 7PE
    Private Limited Company incorporated on 2018-07-02 (7 years). The company status is Active.
    The last date of confirmation statement was made at 2025-04-16
    CIF 0
  • ELLEPHARM INVESTMENTS LIMITED
    S
    Registered number 11443145
    104, Holland Park Avenue, London, England, W11 4UA
    Private Limited Company in Uk Companies House, United Kingdom
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • 104-106 Holland Park Avenue, Holland Park, London
    Active Corporate (3 parents)
    Equity (Company account)
    1,064,767 GBP2024-03-31
    Person with significant control
    2025-04-04 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE
    CIF 1 - Ownership of voting rights - 75% or moreOE
    CIF 1 - Right to appoint or remove directorsOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.